


OWL Lifesciences Revenue
Biotechnology Research • Paris, Île-de-France, France • 1-10 Employees
OWL Lifesciences revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at OWL Lifesciences
Antoni Homs Corbera
Co-Founder
Company overview
| Headquarters | Paris, Île-de-France, France |
| Website | |
| NAICS | 541714 |
| Keywords | Central Nervous System, Advanced Therapeutic Modalities, Ai - Large Biological Model, Assembloid Models Discovery Platform Approach, Biohybrid Computing Discovery Platform Approach, Blood Brain Barrier Models, Cns Advanced In Vitro Models, Therapies Delivery Methods |
| Founded | 2024 |
| Employees | 1-10 |
About OWL Lifesciences
We are a frontier-biotech (techbio) company supporting the discovery and test of therapeutic targets and carriers for Central Nervous System unmet conditions trough our core platform. We follow a Systems biology approach, combining AI and exclusive data issued from the latest advances on animal-free experimental technologies, exclusive models based on in vitro vascularised assembloids and biohybrid computing.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
OWL Lifesciences has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
OWL Lifesciences has never raised funding before.
Frequently asked questions
4.8
40,000 users



